13F HOLDINGS REPORT
TAKEDA PHARMACEUTICAL CO LTD
Quarter ended Q2 2025 · Filed August 8, 2025 · Accession 0001395064-25-000124
Total Value
$19.6M
Positions
12
Other Managers
1
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HilleVax, Inc. | 43157M102 | 6,724,000 | $13.4M | 68.43% |
| 2 | Ovid Therapeutics, Inc. | OVID | 5,750,000 | $1.9M | 9.70% |
| 3 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | XLO | 1,475,121 | $1.0M | 5.13% |
| 4 | American Well Corporation | AMWL | 77,733 | $691,050 | 3.53% |
| 5 | Ovid Therapeutics, Inc. | OVID | 1,781,996 | $587,880 | 3.01% |
| 6 | Equillium, Inc. | EQ | 1,824,977 | $575,233 | 2.94% |
| 7 | Shattuck Labs, Inc. | STTK | 515,619 | $408,267 | 2.09% |
| 8 | Lyell Immunopharma, Inc. | LYEL | 41,165 | $363,906 | 1.86% |
| 9 | Turnstone Biologics | 90042W100 | 895,824 | $321,601 | 1.64% |
| 10 | Third Harmonic Bio, Inc. | 88427A107 | 36,835 | $200,014 | 1.02% |
| 11 | Rani Therapeutics Holdings, Inc. | RANI | 203,190 | $104,419 | 0.53% |
| 12 | Standard Biotools, Inc. | LAB | 16,515 | $19,818 | 0.10% |